Global Health IPO analysis @ Chanakyanipothi.com, India`s Oldest & most Trusted Investment Blog. Operational since 8th December 1999, we are the Only Investment Platform in India, which has successfully completed 21 Years

Listing: The scrip listed at Rs. 401

Global Health Listing Estimate: The company is considered at Taj of Indian Healthcare sector. The IPO received strong response from the institutional investors, whereas on listing selling pressure from RIIs will not be significant (since RII portion was subscribed just 0.88% times). The scrip is expected to list at Rs. 366/370. If you are a long-term investor, you may retain the shares. 

Global Health Grey Market News Today #
for latest updates of Grey Market, Click  

Global Health IPO Subscription Status
# On 7 November 2022 @ 5.00 pm (Last Day)
QIB        :     13524905    Shares,  28.64T
Big NII   :     6643498      Shares,  5.16T
SmallNII:     3321750      Shares,  1.73T
RII         :      23252244    Shares, 0.88T
Total      :     46742397    Shares,  9.58T

Global Health ltd IPO Guidance: Click

Global Health, Company Details
Global Health is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. . Under the “Medanta” brand, it has a network of four hospitals currently in operation (Gurugram, Indore, Ranchi and Lucknow), a hospital which is under construction with an operational outpatient facility (Patna), and one hospital (Noida) planned for development.
As of March 31, 2021, it provides healthcare services in over 30 medical specialties and engage over
1,100 doctors led by highly experienced department heads and, spanning an area of 3.7 million sq. ft., our operational hospitals have 2,176 installed beds.

Global Health was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. He has been awarded the prestigious Padma Bhushan and the Padma Shri, the third and fourth-highest civilian awards in India, and the BC Roy award, in recognition of his distinguished contribution to medicine. Dr. Trehan is the driving force behind its hospitals. It strives to deliver world-class healthcare by establishing institutes of excellence that integrate medical care, teaching and research all while providing affordable medical services to patients. Its hospital at Gurugram was
ranked as the best private hospital in India for two consecutive years in 2020 and 2021 and was the only Indian private hospital to be featured in the list of top 200 global hospitals in 2021 by Newsweek. Its hospital at Gurugram was also featured in the list of world’s best specialized hospitals for cardiology in 2021 by Newsweek
As of March 31, 2019, it had 1,722 installed beds, which grew to 2,176 installed beds as of March 31, 2021, representing a growth of 26.36%. Upon operation of the in-patient department at its Patna hospital in Fiscal 2022 and Noida hospital in Fiscal 2025, it expects the number of total installed beds to exceed 3,500 at the end of Fiscal 2025 which will.
For more information, click https://www.medanta.org

The Promoters of Global Health
Dr. Naresh Trehan

Global Health IPO Main Objects
The Offer comprises of the Fresh Issue and Offer for Sale.
The Company proposes to utilize the Net Proceeds towards Repayment/prepayment of borrowings, in full or part, of its Subsidiaries, GHPPL and MHPL

Global Health IPO Details
IPO opens on 3 November 2022
IPO closes on 7 November 2022
Issue Type: Book Built Issue IPO
Issue: up to 65641952 Shares /Rs2205.57 Crore
* Fresh Issue of 14880952 Sh/ Rs.500 Cr
* Offer for Sale Up to 50,761,000 Sh/ Rs.1705.57 Cr

Face Value per share: Rs. 2

Global Health IPO Price Band Per Equity Share: Rs. 319-336
Global Health IPO Retail Lot Size 44 Shares
Global Health Listing will at BSE, NSE

Shares offered to
QIB (50%) 32820976 Shares = Rs 1102.78 Cr
NII (15%) 9846293 Shares = Rs 330.83 Cr
RII (35%) 22974683 Shares = Rs 771.96 Cr
Lot size: 44 Shares = 522152 Forms
How can you apply?
Min Retail Application:         44    Shares,   Rs. 14784
Max Retail Application:        572   Shares,    Rs 192192
Min Small HNI Application: 616   Shares,    Rs. 206976
Max Small HNI Application: 2948 Shares,    Rs. 990528
Min Big HNI Application:     2992 Shares,    Rs 10,05312

Global Health IPO Tentative timetable
Anchor portion to open on 2 November 2022
IPO opens on 3 November 2022
IPO Closes on 7 November 2022,
Allotment on 11 November 2022
Unblocking of ASBA 14 November 2022
Credit to Demat Accounts 15 November 2022
Listing on 16 November 2022

Global Health IPO Financial & Analytical Ratios
Earnings per Share 2019-20 Rs 1.45
Earnings per Share 2020-21 Rs 1.15
Earnings per Share 2021-22 Rs 7.78
Book Value of the Share as on 31.3.2022 Rs 68.55
Return on Net Worth: 19-20 2.69 %
Return on Net Worth: 20-21: 2.08 %
Return on Net Worth: 20-21: 12.14 %
Equity Shares prior to the IPO: 253,223,925 Shares

Ratio Analysis
Upper Price Band/last EPS: 43.19
Upper offer price/Book Value Ratio: 4.90
Upper offer price/BV after IPO Ratio:

Global Health IPO Peer Comparison:
IPO company @ PE multiple of 43.18
Apollo Hospitals @ PE Multiple of 58.53
Fortis Healthcare @ PE Multiple of 37.31
Max Healthcare @ PE Multiple of 68.55
Narayana Hrudayalaya @ PE Multiple of 43.33

Global Health IPO Lead Managers
Kotak Mahindra Capital, Credit Suisse Securities (India), Jefferies India, J M Financial

Registrar to Global Health IPO
Kfin Technologies India Pvt ltd.

Registered Office of Global Health
Medanta – Mediclinic, E-18, Defence Colony, New Delhi, Delhi 110 024
Company Secretary & Compliance Officer : Rahul Ranjan,

#This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.